Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis

N/ANot Yet RecruitingNCT06645210

Peking University Third Hospital300 enrolled

Overview

To understand the current diagnosis and treatment status of ABPA patients, observe their clinical characteristics, prognosis, and treatment outcomes, and identify the relevant factors for poor prognosis in patients.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Allergic Bronchopulmonary Aspergillosis

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: Meeting the diagnosis of ABPA according to the ABPA diagnostic criteria specified by the ISHAM-ABPA working group in 2024 Exclusion Criteria: ABPA patients who are not first diagnosed in the center

Locations (1)

Peking University Third Hospital

Beijing, Beijing Municipality, China

Outcomes

Primary Outcomes

Clinical classification and treatment response criteria for ABPA

1. Acute ABPA 2. Response 3. Remission 4. Treatment-dependent ABPA 5. Advanced ABPA

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.